BMS-582949 (hydrochloride)
BMS-582949 hydrochloride is an orally active and highly selective p38α MAPK inhibitor, with an IC50 of 13 nM. BMS-582949 hydrochloride displays a significantly improved pharmacokinetic profile and is effective in inflammatory disease[1].
Product Specifications
CAS Number
912806-16-7
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Autophagy; p38 MAPK
Type
Reference compound
Related Pathways
Autophagy; MAPK/ERK Pathway
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/BMS-582949-hydrochloride.html
Concentration
10mM
Purity
98.90
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
O=C(NCCC)C1=CN(N=CN=C2NC3=CC(C(NC4CC4)=O)=CC=C3C)C2=C1C.[H]Cl
Molecular Formula
C22H27ClN6O2
Molecular Weight
442.94
Precautions
H302, H315, H319, H335
References & Citations
[1]Liu C, et al. Discovery of 4- (5- (cyclopropylcarbamoyl) -2-methylphenylamino) -5-methyl-N-propylpyrrolo[1,2-f][1,2,4]triazine-6-carboxamide (BMS-582949), a clinical p38α MAP kinase inhibitor for the treatment of inflammatory diseases. J Med Chem. 2010 Sep 23;53 (18) :6629-39.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
P38α
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC424559 20 µg
Pancreatic alpha amylase (AMY2A) (NM_000699) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNUB0979-100 1x 100 µL
Cytokeratin 8/18 (KRT8/803 + KRT18/835), 0.2mg/mL
Sign In for Pricing
View Details 
